EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS

EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS

The article offers successful application of a preparation of human monoclonal antibodies to tumor necrosis factor (TNF) α – adalimumab – in the setting of a severe course of juvenile idiopathic arthritis characterized by inefficiency of the standard antirheumatic therapy and secondary resistance to...

Full description

Bibliographic Details
Main Authors: E. I. Alexeeva, K. B. Isaeva, R. V. Denisova, T. V. Sleptsova, S. I. Valiyeva, T. M. Bzarova, E. V. Mitenko, A. M. Chomakhidze
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2013-07-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
children
juvenile idiopathic arthritis
adalimumab
treatment
Online Access:https://www.pedpharma.ru/jour/article/view/209

Internet

https://www.pedpharma.ru/jour/article/view/209

Similar Items